1. Introduction {#s0005}
===============

Diabetes is the most common disease as far as metabolic disorder is concerned, its incidence in the year 2010 was 210 million and by 2025 it is proposed to increase to 300 million ([@b0115]). Diabetes mellitus is divided into two types, Type-I and Type-II. Type-II diabetes, however, is also called non-insulin dependent diabetes mellitus, it develops on the root of impaired insulin secretion or increased insulin resistance ([@b0090]). The use of synthetic drugs might be connected with unnecessary side effects, including hypoglycemia and cell death, which are effective in increasing insulin secretion ([@b0055]). Hence, there is an increased scope to develop more safe, effective and cheap methods for its treatment. It is a body's condition where tissues turn resistant to insulin, which results in an evident reduction of glucose metabolism in response to insulin. Recent studies also suggest that insulin resistance results from complex interactions between genetic and environmental factors and is associated with common diseases such as Type-II diabetes, hypertension, obesity and coronary artery disease ([@b0125], [@b0060]). Nowadays researchers are focusing on target based treatment. Piroxicam proliferative activated receptors, glucagon like peptide hormone β3-Adenoreceptor agonist, DPP-IV inhibitors, α-lipoic acid, liver selective glucocorticoid antagonist, PTB-1B inhibitors, glycogen synthase kinase involved in glycogen metabolism, fructose-1, 6-biphosphate as a therapeutic target for Type-II diabetes are the new approaches in the treatment of diabetes mellitus ([@b0115]).

Vanadium is a trace element which is essential for living organisms ([@b0095]). The insulin-like properties of Vanadium provide standard diet which has acknowledged cationic type vanadyl into its anionic type vanadate, which is concentrated in cells. So, vanadyl sulfate used as a choice for the treatment of management of diabetes is linked to their hyperinsulinemic, anti-hyperglycemic and anti hyperlipidemic effects ([@b0005]). In traditional systems, plants are proven to be a good source of herbal medicine for the treatment of diabetes mellitus. Advances in different areas of plant investigation initiated from extraction procedures then isolation, identification, confirmation, design and utilization of bio-assay for efficacy testing, dosage form design, and study of pharmacodynamic, pharmacokinetic, toxicological and pharmacological mode of action ([@b0015]). *Thespesia populnea* belonging to the family Malvaceae has been recommended as an anti-diabetic agent in Ayurvedic Pharmacopoeia of India ([@b0010]). The various experimental findings reveal that *T. populnea* elicited a wide spectrum of activities mainly Antibacterial activity ([@b0040]), Anti-Hepatotoxic activity ([@b0155]), Antisteroidogenic activity ([@b0085]), Cytotoxicity and superoxide anion generation ([@b0075]), Antinociceptive and anti-inflammatory activities ([@b0200]), Anti-psoriatic activity ([@b0160]), Wound healing activity ([@b0100]), Dermatitis ([@b0065]), Anti-oxidant activity ([@b0070]), Alzheimer's Disease ([@b0185]), Antidiabetic activity ([@b0110]), Synergistic activity ([@b0195]), Hypoglycemic, anti-diabetic and anti-ulcer activities ([@b0080]), Immunomodulatory activity ([@b0035]), Anti-inflammatory activity ([@b0140]), α-Amylase Inhibitory Activity ([@b0130]), antiulcer activity ([@b0120]), Antioxidant and anti inflammatory activities ([@b0135]), Memory-Enhancing activity ([@b0190]).

In view of modern studies of phytochemistry, the modified complex of isolated phytochemical constituent exhibits better efficacy and activity. Therefore, the existing research work is aimed at identifying the combined effect of isolated compound thespesone (plant source) and Vanadium (mineral source) on diabetic experimental mice.

2. Experimental {#s0010}
===============

2.1. Plant collection {#s0015}
---------------------

The dry bark of *T. populnea* was collected from a nearby area of Pune, Maharashtra, India. The plant material is authenticated from the Botanical Survey of India with voucher specimen conserved under reference number BSI/WRC/Herbarium/2011.

### 2.1.1. Extraction of bark and isolation of compound {#s0020}

The air dried finely powdered bark was extracted by soxhlet extraction process with 90% hexane, then isolation of the sesquiterpene by using column chromatography with solvent system. The yield was found to be 10% after recrystallization with ethanol.

### 2.1.2. General procedure for synthesis of its metal complex {#s0025}

The isolated compound forms a complex with Vanadium in alkaline condition (Sodium acetate 30 mg) with methanolic solutions of Vanadyl sulfate and the respective ligand in 1:2 (metal:ligand). The reaction mixture was stirred for 6 h at room temperature. The precipitated metal complex was collected by filtration, washed with cold methanol to get pure complex.

2.2. Characterization of isolated thespesone and modified metal complex {#s0030}
-----------------------------------------------------------------------

### 2.2.1. Infrared spectroscopy (IR) {#s0035}

Infrared spectra were recorded using KBr pellets on a Shimadzu 8400S infrared spectrophotometer to know the functional groups present in thespesone and Vanadium complex at the laboratory of Modern College of Pharmacy, Pune ([@b0030], [@b0150]).

### 2.2.2. Electronic absorption spectroscopy {#s0040}

Electronic absorption spectra were recorded on a Shimadzu 1701 UV--VIS spectrophotometer using a matched pair of 1 cm^2^ quartz cells at the laboratory of Modern College of Pharmacy, Pune ([@b0030], [@b0150]).

### 2.2.3. Nuclear magnetic resonance spectroscopy {#s0045}

Proton NMR spectra were measured on a Perkin Elmer instrument Chemistry Department, University of Pune, operating at 300 MHz in CDCl~3~ solvent ([@b0030], [@b0150]).

### 2.2.4. Mass spectroscopy (MS) {#s0050}

The MS analysis of isolated compound was carried out on a API 4000 (Triple Quadruple) using direct Infusion technique in the split mode with scan Type: Q1 MS (Q1) and Ion Spray Voltage is 4200 ([@b0030], [@b0150]).

### 2.2.5. Electron paramagnetic resonance spectroscopy (EPR) {#s0055}

The electron spin resonance studies of all the Vanadium complexes were recorded at 77 K on a Varian X-band spectrometer at the Regional Sophisticated Instruments Center (RSIC), Indian Institute of Technology (IIT) Pavai, Mumbai, India.

2.3. Animals and experimental protocols {#s0060}
---------------------------------------

The study protocol was approved in accordance with the ethical recommendations of animal experimentation protocol (Certificate no: MCP/IAEC/46/2011). The animals had free access to standard pellet (Amrut feeds, Bombay), with water supplied under strict hygienic conditions. The Swiss albino mice weighing 20--30 g were acclimatized for seven days under standard husbandry conditions i.e. room temperature of 25 °C; relative humidity 45--55% of the animal facility at the Modern college of Pharmacy, Pune, Maharashtra, India.

2.4. Acute toxicity study ([@b0105]) {#s0065}
------------------------------------

The acute toxicity study for complex was performed using albino mice followed by OECD 2001 guidelines. The animals were fasted over-night prior to the experiment and maintained under standard conditions.

2.5. Induction of diabetes {#s0070}
--------------------------

To induce diabetes in mice, a single intramuscular injection of Dexamethasone at dose 1 mg/kg/day (Cadila Healthcare Ltd., India) was given to overnight fasted mice from day 1 to 7.

2.6. Dexamethasone induced insulin resistance in mice ([@b0145], [@b0045]). {#s0075}
---------------------------------------------------------------------------

The overnight fasted animals were divided into groups (*n* = 6) as follows, Animals of Group-I received 1% gum acacia (1 ml/kg/day, p.o.) from day 1 to 22. Animals of Group-II received Dexamethasone (1 mg/kg/day, i.m.) from day 1 to 22. Animals of Group-III, IV, V, VI, VII, VIII received Dexamethasone (1 mg/kg/day, i.m.) from day 1 to 7 and Ketoconazole (24 mg/kg/day, p.o), Pioglitazone (2 mg/kg/day, p.o), LVa complex (5 mg/kg/day, p.o.), LVa complex (10 mg/kg/day, p.o.), LVa complex (20 mg/kg/day, p.o), Va (0.2 mM/kg/day, p.o.) from day 8 to 22, respectively.

### 2.6.1. Biochemical parameters {#s0080}

Diabetic animals were weighed before and after drug treatment. On the 22nd day blood was withdrawn by puncturing retro-orbital plexus by using fine glass capillary and collected and further it was used for the estimation of glucose and triglyceride. Biochemical estimation of plasma glucose (GOD/POD Method) and serum triglyceride (GPO/POD Method) was done by using standard diagnostic kits.

2.7. Result interpretation by statistical analysis {#s0085}
--------------------------------------------------

The results are expressed as mean ± SEM and statistically analyzed by Analysis of Variance (ANOVA) followed by Dunnett test, with level of significance set at *p *\< 0.05, ^\*\*^*p* \< 0.01.

3. Result and discussion {#s0090}
========================

3.1. Characterization of isolated thespesone and modified metal complex {#s0095}
-----------------------------------------------------------------------

The compound (Thespesone) molecular formula is C~15~H~14~O~4~. The Infrared spectrum of synthesized Vanadium complex seen at different frequencies like OH at 3410.26 and C000000000000 000000000000 000000000000 111111111111 000000000000 111111111111 000000000000 000000000000 000000000000C at 1610.61 and the spectra of Vanadium complex are given in [Fig. 1](#f0005){ref-type="fig"}. The Electronic absorption spectra of compound were carried out by using DMSO solvent, *λ*max was found to be 289. The NMR signal of the CH2 group appears at *δ* ∼1.70 of B ring and 2.38 of A ring. *δ* ∼3.24 of B ring, *δ* ∼4.69 and *δ* ∼4.57 in C ring. The CH3 group appears at *δ* ∼1.48 of C ring, signal of the CH group in C ring appears at *δ* ∼4.28 and aromatic proton of A ring appears at *δ* ∼6.94 and Mass Spectroscopy analysis of isolated compound shows at *m*/*z* 258.2 it confirms the identity structure of Thespesone ([@b0030], [@b0150]).

The EPR spectra of the Vanadium complex provided information on metal ion environment and the electron delocalization ([Table 1](#t0005){ref-type="table"}). The X-band EPR spectra of Vanadium complex, were recorded in DMSO glass at 77 K. The four well-resolved metal hyperfines in the low field region are indicative of monomeric and Vanadium complex which gives conformation about the complex.

3.2. Acute toxicity study {#s0100}
-------------------------

From acute toxicity study it was found that the Vanadium complex was found safe up to a dose of 100 mg/kg, orally.

3.3. Dexamethasone induced insulin resistance in mice {#s0105}
-----------------------------------------------------

In the adipocyte tissue glucocorticoids induce the *ob gene* expression within 24 h then followed by multifaceted metabolic changes resulting in fall of body weight, decline in food consumption, usually accompanied by diabetes and the development of insulin resistance along with increased blood glucose and triglyceride level. Different mechanisms for corticosteroids have been advocated for the increase in glucose level, one of them being insulin resistance caused by the altered binding of insulin receptors ([@b0145], [@b0045]). Ketoconazole is an anti-glucocorticoid drug mainly, which inhibits the synthesis of cortisol and it prevents insulin resistance activity of dexamethasone ([@b0165]).

In the skeletal muscle, glucocorticoids reduce the rate of basal and insulin-stimulated glucose uptake, although the chronic accumulation of glycogen is improved. Glucocorticoid-induced insulin resistance is credited mainly to a post-receptor failing of insulin action, but this does not decrease the insulin-sensitive glucose transporter isoform GLUT 4 mRNA or GLUT 4 abundance in muscle membranes ([@b0180]).

The development of non insulin dependent diabetes mellitus was characterized by increased insulin resistance and failure of normal β-cell activity resulting in a slow decrease in insulin secretion ([@b0170], [@b0175]). Vanadium is an essential element which converted cationic type vanadyl into its anionic type vanadate in cells. Vanadate as a potent inhibitor of Na^+^--K^+^ ATPase increases the release of insulin from the pancreatic β-cells ([@b0025]) and stimulates GTUT 4 so that glucose transport across the cell increases ([@b0020]).

In the present study, dexamethasone administered for 22 days produced significant increase in blood glucose and triglyceride level. The treatment with Keto, Pio and different doses of Vanadium complex prevented the rise in plasma glucose due to dexamethasone ([Figure 3](#f0015){ref-type="fig"}, [Figure 4](#f0020){ref-type="fig"}). The anti-hyperglycemic activity of Vanadium complex in dexamethasone treated animals appears to be mediated by decreasing the peripheral insulin resistance or by suppressing enzymes involved in hepatic gluconeogenesis or by stimulating glucose uptake in the peripheral tissues ([@b0045]). There was a decrease in relative body weight of the diabetic mice compared to control mice ([Fig. 2](#f0010){ref-type="fig"}). Treatment of diabetic mice with Vanadium complex increases the reduced body weight by altering gluconeogenesis, glycolysis prevention, lipolysis and causing an imbalance in lipid metabolism. The plant *T. populnea* is also reported to have hepatoprotective activity. Thus in the present study the antihyperlipidemic activity of the Vanadium complex in dexamethasone treated animal is likely to be mediated by decreasing the lipolysis due to its antioxidant and hepatoprotective activities ([@b0050]), also plays a role in the stimulatory action of Vanadium complex on glucose uptake.

4. Conclusions {#s0110}
==============

In the results of the present study, it was observed that the Vanadium complex found may prove to be useful in the treatment of diabetes mellitus probably by overcoming the insulin resistance. Further, Vanadium complex also prevents the progressive increase in glucose and triglyceride level and decrease in body weight caused by dexamethasone. Complex may significantly increase glucose uptake, which indicates that there was boost in the insulin sensitivity.
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###### 

Electron paramagnetic resonance parameters (at 77 K in DMSO glass) for Vanadium complexes (at 300 K). LVa--Thespesone--Vanadium complex.

  Compound   *g*~‖~   *g*~⊥~   *A*   *F* (cm^−1^)
  ---------- -------- -------- ----- --------------
  LVa        1.99     1.98     190   106
